Biologics for Osteoporosis: Where Do We Stand?

Gheita Tamer A, Fathi Hanan M
{"title":"Biologics for Osteoporosis: Where Do We Stand?","authors":"Gheita Tamer A, Fathi Hanan M","doi":"10.23937/2572-3243.1510059","DOIUrl":null,"url":null,"abstract":"Citation: Gheita TA, Fathi HM (2018) Biologics for Osteoporosis: Where Do We Stand?. J Musculoskelet Disord Treat 4:059. doi.org/10.23937/2572-3243.1510059 Accepted: November 10, 2018: Published: November 12, 2018 Copyright: © 2018 Gheita TA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Biologics for Osteoporosis: Where Do We Stand?","PeriodicalId":16374,"journal":{"name":"Journal of musculoskeletal disorders and treatment","volume":"9 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of musculoskeletal disorders and treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23937/2572-3243.1510059","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

Citation: Gheita TA, Fathi HM (2018) Biologics for Osteoporosis: Where Do We Stand?. J Musculoskelet Disord Treat 4:059. doi.org/10.23937/2572-3243.1510059 Accepted: November 10, 2018: Published: November 12, 2018 Copyright: © 2018 Gheita TA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Biologics for Osteoporosis: Where Do We Stand?
骨质疏松的生物制剂:我们在哪里?
引用本文:Gheita TA, Fathi HM(2018)骨质疏松症生物制剂:我们站在哪里?肌肉骨骼疾病治疗[J];doi.org/10.23937/2572-3243.1510059接收日期:2018年11月10日发布日期:2018年11月12日版权所有:©2018 Gheita TA等。这是一篇根据知识共享署名许可协议发布的开放获取文章,该协议允许在任何媒体上不受限制地使用、分发和复制,前提是要注明原作者和来源。骨质疏松的生物制剂:我们在哪里?
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信